About
Sarah Korman is Chief Business and Legal Officer at Isomorphic Labs, where she leads legal and business functions for an AI-driven drug design company. She previously served as Chief Legal Officer at Absci and earlier held legal and intellectual-property roles at Neuvogen, Amgen, Onyx Pharmaceuticals, and the World Intellectual Property Organization. She also serves on the Board of the BioIndustry Association and has a PhD, JD, and patents related to nano-enabled therapeutics and drug delivery.
Areas of interest
AIdrug discoverybiotechlife sciencesintellectual propertybusiness developmentresponsible AI policynanotechnology-enabled therapeuticsdrug delivery